Trial result ·
Association between neutrophil percentage-to-albumin ratio and vascular cognitive impairment in patients with cerebrovascular disease: a cross-sectional study.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This study looked at a blood marker called NPAR. It combines one type of white blood cell with a blood protein, albumin. The marker is thought to show inflammation and food-related health. The team asked if NPAR was tied to thinking issues. All people had disease of the brain's blood vessels. They studied 227 people whose disease came from blocked blood flow. Of these, 130 had thinking issues and 97 had normal thinking. Each person was checked once, at one point in time.
What they found
People with thinking issues had higher NPAR levels than those without. The team took other health factors into account. After that, higher NPAR was still linked to having thinking issues. Other ways of looking at the data gave much the same result. The link rose in a roughly straight line across the levels seen. NPAR on its own told the groups apart fairly well. But it added little beyond the usual health facts doctors use.
What it means for patients
In these people, higher NPAR went along with thinking issues. The authors say NPAR may give extra facts when doctors check for these issues. They also say the results should be read with care.
Why it is not certain yet
The study looked at each person at one point in time only. So it cannot show that NPAR causes thinking issues. The authors say larger studies are needed to check the results. Those studies should follow people forward in time. Also, NPAR added only limited value beyond usual health facts.
Source
Association between neutrophil percentage-to-albumin ratio and vascular cognitive impairment in patients with cerebrovascular disease: a cross-sectional study.
PubMed · PMID 42056952We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Vascular dementia publications